Skip to content

Clinical trials

Observational Ovarian Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Observational Country / region: United States Clear all

194 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20024
20035
20045
20056
20069
200710
20086
200912
20106
20119
20123
20137
20146
20157
20168
20176
20186
20199
20206
202110
20226
20234
20246
202510
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98
Recruiting32
Terminated21
Unknown status16
Active, not recruiting14
Withdrawn6
Not yet recruiting3
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center17
Memorial Sloan Kettering Cancer Center16
National Cancer Institute (NCI)15
Gynecologic Oncology Group11
Abramson Cancer Center at Penn Medicine5
Mayo Clinic4
NYU Langone Health4
University of Washington4
Fujirebio Diagnostics, Inc.3
National Human Genome Research Institute (NHGRI)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms194
Breast Neoplasms60
Fallopian Tube Neoplasms42
Endometrial Neoplasms34
Lung Neoplasms30
Neoplasms30
Uterine Cervical Neoplasms28
Pancreatic Neoplasms27
Colorectal Neoplasms25
Carcinoma, Ovarian Epithelial23

Trials

Showing 1 to 25 of 194. Each trial links to its page on Pharma Observatory.

94 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.